SEM of the developing nematode sperm cytoskeleton. - Nematode sperm = activation involves the reorganization of specialized organelles and the rapid assembly of the MSP protein cytoskeleton in the amoeboid sperm. Because the Ascaris sperm cytoskeleton is visible in live cells with enhanced DIC, it is a valuable phenomenological model for amoeboid motility. Interest has developed in assembling a detailed 3D picture of the structure of this system in anticipation of the rapidly evolving biochemistry of MSP in Tom Robert's lab. The project requires the use of the Hitachi S-900 to demonstrate the association of cytoskeleton and plasma membrane, the 3D organization of the developing cytoskeleton (fiber complexes), and for the immunocytochemistry of assembling MSP and recently discovered CAP particles associated with the developing cytoskeleton. Dr. Sepsenwol has prepared a timed-activation series of anti-MSP and anti-CAP labelled """"""""wet-ripped"""""""" cells for this purpose. He has initiated cryo-SEM studies of fractured inactive and fully activated sperm with the high pressure freezer to demonstrate the presence of skeletal structures seen in fixed cells. Correlative 2-photon, IR laser scanning microscopy of activating and crawling nematode sperm - LM of live Ascaris sperm has been limited to visible-light techniques (enhanced DIC): the cell's exquisite sensitivity to short-wavelength illumination has precluded continuous fluorescence studies with dyes useful for studying the early activation events in living cells.This has now become possible with the prototype 2-photon IR laser scanning LM at the IMR Dr. Sepsenwol has used the instrument to follow fluorescently-labelled live cells from the very first events in activation to their behavior during full motility for more than one hour (vs. seconds by epifluorescence or laser-confocal microscopy). In addition, Presumed cell-cell chemotaxis has been observed in packs of crawling sperm by taking advantage of 2-photonoptical sectioning capability. Using the membrane probe FM4-64, the exact time of a critical and ephemeral event in pseudopod assembly - membranous organelle [MO] fusion - can be determined. MO fusion precedes the elaboration of new pseudopod membrane, and the polymerization of the first cytoskeleton. It has been postulated that the MO provides this new membrane. By timing fixation with these events, a series of whole-mount and plastic-embedded samples of early pseudopod formation have been generated for examination with the S-900 SEM. The first views of SEM whole mounts show giant pores forming in a vortex of (new) plasma membrane at the MO fusion sites. Later studies will look at whether the MO's provide the cytoskeleton polymerization sites known to exist in the mature sperm pseudopod membrane. Additional projects have been suggested by results obtained with other dyes that fluoresce well with the IR 2-photon system: JC- 1, a potential-sensistive mitochondrial dye, shows a change in mitochondrial activity during activation, and Rhodamine 123 shows a dramatic compartmentalization between cell body and pseudopod, although there does not appear to be an anatomical barrier in EM studies.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
3P41RR000570-27S1
Application #
2757597
Study Section
Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
27
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Malecki, Marek; Putzer, Emily; Sabo, Chelsea et al. (2014) Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies. Mol Cell Ther 2:
Malecki, Marek (2014) 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther 5:73
Mavroudi, Maria; Zarogoulidis, Paul; Porpodis, Konstantinos et al. (2014) Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy. J Cancer Res Ther (Manch) 2:22-33
Malecki, Marek; LaVanne, Christine; Alhambra, Dominique et al. (2013) Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent J Stem Cell Res Ther Suppl 9:
Malecki, Marek; Tombokan, Xenia; Anderson, Mark et al. (2013) TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther 3:
Malecki, Marek (2013) Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. J Stem Cell Res Ther 3:
Malecki, Marek; Dahlke, Jessica; Haig, Melissa et al. (2013) Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer. J Genet Syndr Gene Ther 4:152
Zarogoulidis, Paul; Darwiche, Kaid; Sakkas, Antonios et al. (2013) Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther 4:
Malecki, Marek; Sabo, Chelsea; Putzer, Emily et al. (2013) Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration. Mol Cell Ther 1:
Malecki, Marek; Malecki, Bianca (2012) Routing of Biomolecules and Transgenes' Vectors in Nuclei of Oocytes. J Fertili In Vitro 2012:108-118

Showing the most recent 10 out of 24 publications